A New Frontier in Functional Eye Imaging

The study, titled “Retinal Imaging in Degeneration and Regeneration,” is led by Dr. Jeffrey Goldberg, Professor and Chair of Ophthalmology at the Byers Eye Institute. A global leader in his field, Dr. Goldberg’s research focuses on the neuroprotection and regeneration of the optic nerve—an area of critical unmet need for treating diseases like glaucoma.

“Many sight-threatening diseases progress silently, and by the time structural damage is visible, it’s often irreversible,” said Dr. Goldberg. “By incorporating functional imaging technologies like targeted ocular oximetry, we aim to detect early metabolic changes that could inform next-generation therapies—and potentially restore vision.”

Beyond Anatomy: A Functional Window into the Eye

While traditional imaging tools focus on structure, the Zilia Ocular adds a crucial functional layer by non-invasively measuring tissue oxygen saturation in targeted regions of the eye. These measurements may provide early insights into disease activity and a patient’s response to treatment, long before a patient experiences vision loss.
“Being able to quantify oxygen dynamics in the eye is a leap forward for both research and clinical care,” said Dr. Patrick Sauvageau, optometrist, CEO and Co-founder of Zilia. “We are honored to contribute to this important initiative at the Byers Eye Institute.”

About Zilia

Zilia is a health technology company developing a groundbreaking platform to non-invasively measure biomarkers in the eye, with an initial focus on ocular oximetry. By integrating advanced photonics and artificial intelligence, Zilia’s first-of-kind technology is intended to leverage the eye’s optical properties and its direct connections to the vascular system and the brain, capturing critical information on ocular and overall health.

For Further Information

Zilia: https://ziliahealth.com/